PIPELINE

Candidate Indication Development status
  • Research
  • Lead Optimization
  • In Vitro
  • In Vivo
  • Phase Ⅰ
  • Phase Ⅱ
  • Phase Ⅲ
  • NDA
  • Commercialization
miR - based Gene Therapy ANL-101 Alzheimer´s Disease
In Vivo

ANL-102 MCI
Lead Optimization

ANL-103 Parkinson´s Disease
Lead Optimization

Monogenic gene therapy ANL-301 Undisclosed
In Vitro

ANL-302 Undisclosed
Lead Optimization

ANL-303 Undisclosed
Research

좌우로 스크롤 하시면 전체 내용을 확인할 수 있습니다.